首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF THE DEXTRO AND LAEVO ISOMERS OF SOTALOL

PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF THE DEXTRO AND LAEVO ISOMERS OF SOTALOL

机译:包含索他洛尔右旋异构体和左旋异构体的药物组合物

摘要

Antiarrhythmic composition with controlled beta -adrenergic blockade comprises a combination of dextro- and laevo-rotatory isomers of sotalol or their salts in a ratio of 1.5:1-3.5:1. An independent claim is included for an oral or parenteral composition for treating cardiac ailments which comprises a combination of dextro- and laevo-isomers of sotalol. ACTIVITY : Antiarrhythmic; cardiant. In a test using Guinea pigs (Dunken Hartley) to demonstrate antiarrhythmic activity of different ratios of sotalol, ouabain was used to produce ventricular tachycardia. Sotalol (2:1 ratio (d:l)) resulted in complete protection against ventricular tachycardia at a dosage of 2.5 mg/kg. MECHANISM OF ACTION : beta -adrenergic antagonist.
机译:具有受控的β-肾上腺素能阻滞的抗心律失常组合物包含比例为1.5:1-3.5:1的索他洛尔或其盐的右旋和左旋旋转异构体的组合。包括用于治疗心脏病的口服或肠胃外组合物的独立权利要求,其包含索他洛尔的右旋异构体和左旋异构体的组合。活动:抗心律失常;卡迪恩在使用豚鼠(Dunken Hartley)进行的试验中,证明了不同比例的talal的抗心律失常活性,哇巴因被用于产生室性心动过速。索他洛尔(2:1的比例(d:l))以2.5 mg / kg的剂量可完全预防心室性心动过速。作用机理:β-肾上腺素能拮抗剂。

著录项

  • 公开/公告号AT241349T

    专利类型

  • 公开/公告日2003-06-15

    原文格式PDF

  • 申请/专利权人 TORRENT PHARMACEUTICALS LTD;

    申请/专利号AT19990902781T

  • 发明设计人 SANKARANARAYANAN ALANGUDI;

    申请日1999-02-22

  • 分类号A61K31/18;

  • 国家 AT

  • 入库时间 2022-08-21 23:59:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号